Innerva Pharmaceuticals
Innerva Pharmaceuticals, S.L. is developing innovative therapies for ocular surface pain, focusing on improving eye health and providing effective solutions to enhance comfort and quality of life for patients.
About Innerva Pharmaceuticals
Innerva Pharmaceuticals is a biotechnology and pharmaceutical startup founded in 2021 in Barcelona, Catalonia, Spain, focused on developing novel treatments for Ocular Surface Pain a significant unmet need in ophthalmology. The company was established by serial biotech entrepreneur Patrick Tresserras and Professor Carlos Belmonte, a renowned physiologist and expert in pain neuroscience, who together bring deep scientific and industry experience to advance first-in-class therapies. Since its founding, Innerva has pursued innovative pharmacological approaches to alleviate ocular pain associated with dry eye and other surface diseases, leveraging licensed technology and strategic funding to drive its development toward clinical applications.



